Site Management Organization
For our sponsor managed studies, Pharmatech Oncology functions as a Site Management Organization (SMO) to help maximize the outcomes and data quality of each clinical trial. Pharmatech Oncology works to improve patient recruitment and address site-specific issues while supporting investigative sites’ initiatives to enroll patients through:
- Site identification, selection, and management
- Centralized contracting
- Management of regulatory documents
- Grant management
- Research advisory and investigator meetings
Pharmatech Oncology Announces Completion of SBIR Grant Research
10/19/2011
Pharmatech Oncology Announces ASH Abstract
10/11/2010
Press Release from Tamir Biotechnologies
7/6/2010
Pharmatech Oncology's Presentation at 46th Annual DIA Meeting
6/25/2010
Pharmatech Oncology to Present at 46th Annual DIA Meeting
6/10/2010
